Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines

10.1371/journal.pone.0131156

Saved in:

Bibliographic Details
Main Authors:	Haasis M.A., Ceria J.A., Kulpeng W., Teerawattananon Y., Alejandria M.
Other Authors:	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format:	Article
Published:	Public Library of Science 2020
Subjects:	Pneumococcus conjugate vaccine 10 Pneumococcus vaccine unclassified drug 10-valent pneumococcal conjugate vaccine 13-valent pneumococcal vaccine vaccine Article cohort analysis cost effectiveness analysis cost utility analysis drug cost drug efficacy economic evaluation government health care access health care cost health care delivery herd immunity human Philippines pneumococcal infection preventive health service program sustainability quality adjusted life year statistical model adolescent adult aged child cost benefit analysis drug effects economics female financial management immunology income infant male Markov chain microbiology middle aged newborn Pneumonia, Pneumococcal preschool child Streptococcus pneumoniae vaccination Adolescent Adult Aged Child Child, Preschool Cost-Benefit Analysis Female Financing, Government Humans Immunization Programs Income Infant Infant, Newborn Male Markov Chains Middle Aged Pneumococcal Vaccines Vaccination Vaccines, Conjugate
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/165692
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-165692
record_format	dspace
spelling	sg-nus-scholar.10635-1656922024-11-10T03:56:46Z Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines Haasis M.A. Ceria J.A. Kulpeng W. Teerawattananon Y. Alejandria M. SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Pneumococcus conjugate vaccine 10 Pneumococcus vaccine unclassified drug 10-valent pneumococcal conjugate vaccine 13-valent pneumococcal vaccine Pneumococcus vaccine vaccine Article cohort analysis cost effectiveness analysis cost utility analysis drug cost drug efficacy economic evaluation government health care access health care cost health care delivery herd immunity human Philippines pneumococcal infection preventive health service program sustainability quality adjusted life year statistical model adolescent adult aged child cost benefit analysis drug effects economics female financial management immunology income infant male Markov chain microbiology middle aged newborn Pneumonia, Pneumococcal preschool child Streptococcus pneumoniae vaccination Adolescent Adult Aged Child Child, Preschool Cost-Benefit Analysis Female Financing, Government Humans Immunization Programs Income Infant Infant, Newborn Male Markov Chains Middle Aged Philippines Pneumococcal Vaccines Pneumonia, Pneumococcal Streptococcus pneumoniae Vaccination Vaccines, Conjugate 10.1371/journal.pone.0131156 PLoS ONE 10 7 e0131156 2020-03-19T03:01:15Z 2020-03-19T03:01:15Z 2015 Article Haasis M.A., Ceria J.A., Kulpeng W., Teerawattananon Y., Alejandria M. (2015). Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines. PLoS ONE 10 (7) : e0131156. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0131156 19326203 https://scholarbank.nus.edu.sg/handle/10635/165692 Public Library of Science Unpaywall 20200320
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Pneumococcus conjugate vaccine 10 Pneumococcus vaccine unclassified drug 10-valent pneumococcal conjugate vaccine 13-valent pneumococcal vaccine Pneumococcus vaccine vaccine Article cohort analysis cost effectiveness analysis cost utility analysis drug cost drug efficacy economic evaluation government health care access health care cost health care delivery herd immunity human Philippines pneumococcal infection preventive health service program sustainability quality adjusted life year statistical model adolescent adult aged child cost benefit analysis drug effects economics female financial management immunology income infant male Markov chain microbiology middle aged newborn Pneumonia, Pneumococcal preschool child Streptococcus pneumoniae vaccination Adolescent Adult Aged Child Child, Preschool Cost-Benefit Analysis Female Financing, Government Humans Immunization Programs Income Infant Infant, Newborn Male Markov Chains Middle Aged Philippines Pneumococcal Vaccines Pneumonia, Pneumococcal Streptococcus pneumoniae Vaccination Vaccines, Conjugate
spellingShingle	Pneumococcus conjugate vaccine 10 Pneumococcus vaccine unclassified drug 10-valent pneumococcal conjugate vaccine 13-valent pneumococcal vaccine Pneumococcus vaccine vaccine Article cohort analysis cost effectiveness analysis cost utility analysis drug cost drug efficacy economic evaluation government health care access health care cost health care delivery herd immunity human Philippines pneumococcal infection preventive health service program sustainability quality adjusted life year statistical model adolescent adult aged child cost benefit analysis drug effects economics female financial management immunology income infant male Markov chain microbiology middle aged newborn Pneumonia, Pneumococcal preschool child Streptococcus pneumoniae vaccination Adolescent Adult Aged Child Child, Preschool Cost-Benefit Analysis Female Financing, Government Humans Immunization Programs Income Infant Infant, Newborn Male Markov Chains Middle Aged Philippines Pneumococcal Vaccines Pneumonia, Pneumococcal Streptococcus pneumoniae Vaccination Vaccines, Conjugate Haasis M.A. Ceria J.A. Kulpeng W. Teerawattananon Y. Alejandria M. Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines
description	10.1371/journal.pone.0131156
author2	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
author_facet	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Haasis M.A. Ceria J.A. Kulpeng W. Teerawattananon Y. Alejandria M.
format	Article
author	Haasis M.A. Ceria J.A. Kulpeng W. Teerawattananon Y. Alejandria M.
author_sort	Haasis M.A.
title	Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines
title_short	Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines
title_full	Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines
title_fullStr	Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines
title_full_unstemmed	Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines
title_sort	do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? a cost-utility analysis in the philippines
publisher	Public Library of Science
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/165692
_version_	1821198146379710464

Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines

Similar Items